LS
Lori Styles
Pediatrics / Pediatric Hematology-Oncology
Credentials: ·
Research
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2015 · 1,331 citations
The Lancet Oncology · 2019 · 481 citations
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
Blood · 2017 · 415 citations
31 papers
- CH
14 papers · 5 as a fellow
- DJ
9 papers
8 papers
8 papers
7 papers
6 papers
- CZ
4 papers · 4 as a resident
